Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 97

Similar articles for PubMed (Select 20808229)

1.

A formal risk-benefit framework for genomic tests: facilitating the appropriate translation of genomics into clinical practice.

Veenstra DL, Roth JA, Garrison LP Jr, Ramsey SD, Burke W.

Genet Med. 2010 Nov;12(11):686-93. doi: 10.1097/GIM.0b013e3181eff533.

2.

Stakeholder perspectives on a risk-benefit framework for genetic testing.

Roth JA, Garrison LP Jr, Burke W, Ramsey SD, Carlson R, Veenstra DL.

Public Health Genomics. 2011;14(2):59-67. doi: 10.1159/000290452. Epub 2010 Apr 20.

3.

A risk-benefit analysis of factor V Leiden testing to improve pregnancy outcomes: a case study of the capabilities of decision modeling in genomics.

Bajaj PS, Veenstra DL.

Genet Med. 2013 May;15(5):374-81. doi: 10.1038/gim.2012.139. Epub 2012 Nov 8.

PMID:
23138100
4.

A policy model to evaluate the benefits, risks and costs of warfarin pharmacogenomic testing.

Meckley LM, Gudgeon JM, Anderson JL, Williams MS, Veenstra DL.

Pharmacoeconomics. 2010;28(1):61-74. doi: 10.2165/11318240-000000000-00000.

PMID:
20014877
5.

American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.

American Society of Clinical Oncology.

J Clin Oncol. 2003 Jun 15;21(12):2397-406. Epub 2003 Apr 11.

PMID:
12692171
6.

Review of guidelines for good practice in decision-analytic modelling in health technology assessment.

Philips Z, Ginnelly L, Sculpher M, Claxton K, Golder S, Riemsma R, Woolacoot N, Glanville J.

Health Technol Assess. 2004 Sep;8(36):iii-iv, ix-xi, 1-158. Review.

8.

Personalized medicine and genomics: challenges and opportunities in assessing effectiveness, cost-effectiveness, and future research priorities.

Conti R, Veenstra DL, Armstrong K, Lesko LJ, Grosse SD.

Med Decis Making. 2010 May-Jun;30(3):328-40. doi: 10.1177/0272989X09347014. Epub 2010 Jan 4.

PMID:
20086232
9.
10.

Methods for the comparative evaluation of pharmaceuticals.

Zentner A, Velasco-Garrido M, Busse R.

GMS Health Technol Assess. 2005 Nov 15;1:Doc09.

11.

Evidence-based classification of recommendations on use of genomic tests in clinical practice: dealing with insufficient evidence.

Khoury MJ, Coates RJ, Evans JP.

Genet Med. 2010 Nov;12(11):680-3. doi: 10.1097/GIM.0b013e3181f9ad55.

PMID:
20975567
12.

Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2006;6(20):1-180. Epub 2006 Nov 1.

13.
14.

Evaluating genomic tests from bench to bedside: a practical framework.

Lin JS, Thompson M, Goddard KA, Piper MA, Heneghan C, Whitlock EP.

BMC Med Inform Decis Mak. 2012 Oct 19;12:117. doi: 10.1186/1472-6947-12-117.

15.

Procedures and methods of benefit assessments for medicines in Germany.

Bekkering GE, Kleijnen J.

Eur J Health Econ. 2008 Nov;9 Suppl 1:5-29. doi: 10.1007/s10198-008-0122-5.

PMID:
18987905
16.

Primary Care Research Team Assessment (PCRTA): development and evaluation.

Carter YH, Shaw S, Macfarlane F.

Occas Pap R Coll Gen Pract. 2002 Feb;(81):iii-vi, 1-72.

17.

Risk management frameworks for human health and environmental risks.

Jardine C, Hrudey S, Shortreed J, Craig L, Krewski D, Furgal C, McColl S.

J Toxicol Environ Health B Crit Rev. 2003 Nov-Dec;6(6):569-720. Review.

PMID:
14698953
18.

[Procedures and methods of benefit assessments for medicines in Germany].

Bekkering GE, Kleijnen J.

Dtsch Med Wochenschr. 2008 Dec;133 Suppl 7:S225-46. doi: 10.1055/s-0028-1100954. Epub 2008 Nov 25. German.

PMID:
19034813
19.

Clinical utility of serologic testing for celiac disease in ontario: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2010;10(21):1-111. Epub 2010 Dec 1.

20.

Closing the gap between knowledge and clinical application: challenges for genomic translation.

Burke W, Korngiebel DM.

PLoS Genet. 2015 Feb 26;11(2):e1004978. doi: 10.1371/journal.pgen.1004978. eCollection 2015. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk